Exploring the effect of quercetin flavonoid encapsulated in chitosan nanoparticles on cytotoxicity, apoptosis, and growth of human cancer cell line

Subject Areas : Journal of Comparative Pathobiology

روح الله Kamyabi ¹ (Department of Basic Science, Faculty of Veterinary Medicine, Science and Research Branch, Tehran, Iran)
علیرضا Jahandideh ² (Department of Clinical Science, Faculty of Veterinary Medicine, Science and Research Branch, Tehran,)
نگار Panahi ³ (Department of Basic Science, Faculty of Veterinary Medicine, Science and Research Branch, Tehran, Iran)
صمد MohamamdNezhad ⁴ (Gene Research Center, Tehran university of Medical Sciences, Tehran, Iran)

Received: 2023-02-26 Accepted : 2023-05-07 Published : 2023-08-23

Keywords: Quercetin, Nanomedicine, Chitosan, K562,

Abstract :

Cancer is one of the most important causes of death in today's societies. Intolerable side effects and resistance to chemotherapy drugs have encouraged scientists to invent new drug compounds with less side effects. This study aimed to evaluate the synergistic effects of quercetin encapsulated in chitosan nanoparticles on cytotoxicity, apoptosis, and cell growth of K562 cell line. The flavonoid quercetin was encapsulated in chitosan nanoparticles and their physical characteristics were determined using standard methods, FTIR and SEM microscope images. K562 cells were cultured in cell culture medium, the cytotoxicity of drugs was evaluated by MTT method and the effects of nanodrugs on apoptosis in them were evaluated by flow cytometry. IC50 during 24- and 48-hours exposure of cells with nanoquercetin drug was determined as 16.71 and 10.36 μg/ml. Quercetin nanomedicine had a positive zeta potential. The data showed that the form of quercetin nanomedicine encapsulated with chitosan compared to the pure form of quercetin had a statistically significant effect on cancer cells (p<0.05). The results of the present study show that the encapsulated form of quercetin nanomedicine with chitosan has more cytotoxicity than the pure form of drugs. On the other hand, the results showed that quercetin in the form of a nano-drug complex had a significant effect in inducing apoptosis in human chronic myeloid leukemia cells. Therefore, this nanomedicine can be further investigated in the treatment of chronic myeloid leukemia.

References:

1. Minciacchi VR, Kumar R, Krause DS. Chronic myeloid leukemia: a model disease of the past, present and future. Cells. 2021;10(1):117.


2. Hsieh Y-C, Kirschner K, Copland M. Improving outcomes in chronic myeloid leukemia through harnessing the immunological landscape. Leukemia. 2021;35(5):1229-42.


3. Cortes J, Lang F. Third-line therapy for chronic myeloid leukemia: current status and future directions. Journal of Hematology & Oncology. 2021;14(1):1-18.


4. Adnan-Awad S, Kim D, Hohtari H, Javarappa KK, Brandstoetter T, Mayer I, et al. Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets. Leukemia. 2021;35(7):1964-75.


5. Zhang L, Meng L, Liu B, Zhang Y, Zhu H, Cui J, et al. Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd Study. Clinical Cancer Research. 2021;27(1):70-7.

6. Garcia-Gutiérrez V, Luna A, Alonso-Dominguez JM, Estrada N, Boque C, Xicoy B, et al. Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice. Blood Cancer Journal. 2021;11(2):1-4.


7. Erdenetsogt U, Nadmid S, Paulus C, Chanagsuren G, Dolgor E, Gotov C, et al. Bioactive flavonoids from plant extract of Pyrethrum pulchrum and its acute toxicity. Natural Product Research. 2021;35(24):5960-3.


8. Mottaghi S, Abbaszadeh H. The anticarcinogenic and anticancer effects of the dietary flavonoid, morin: Current status, challenges, and future perspectives. Phytotherapy Research. 2021.


9. Zuo S, Sun L, Wang Y, Chen B, Wang J, Ge X, et al. Establishment of a novel mesenchymal stem cell-based regimen for chronic myeloid leukemia differentiation therapy. Cell death & disease. 2021;12(2):1-15.


10. Mutlu Altundağ E, Yılmaz AM, Serdar BS, Jannuzzi AT, Koçtürk S, Yalçın AS. Synergistic induction of apoptosis by quercetin and curcumin in chronic myeloid leukemia (K562) cells: II. Signal transduction pathways involved. Nutrition and Cancer. 2021;73(4):703-12.


11. Mohammed HA, Sulaiman GM, Anwar SS, Tawfeeq AT, Khan RA, Mohammed SA, et al. Quercetin against MCF7 and CAL51 breast cancer cell lines: apoptosis, gene expression and cytotoxicity of nano-quercetin. Nanomedicine. 2021;16(22):1937-61.


12. Ghafouri-Fard S, Shabestari FA, Vaezi S, Abak A, Shoorei H, Karimi A, et al. Emerging impact of quercetin in the treatment of prostate cancer. Biomedicine & Pharmacotherapy. 2021;138:111548.


13. Almatroodi SA, Alsahli MA, Almatroudi A, Verma AK, Aloliqi A, Allemailem KS, et al. Potential therapeutic targets of quercetin, a plant flavonol, and its role in the therapy of various types of cancer through the modulation of various cell signaling pathways. Molecules. 2021;26(5):1315.


14. Molani Gol R, Kheirouri S. The Effects of Quercetin on the Apoptosis of Human Breast Cancer Cell Lines MCF-7 and MDA-MB-231: A Systematic Review. Nutrition and Cancer. 2021:1-18.


15. Mawalizadeh F, Mohammadzadeh G, Khedri A, Rashidi M. Quercetin potentiates the chemosensitivity of MCF-7 breast cancer cells to 5-fluorouracil. Molecular Biology Reports. 2021;48(12):7733-42.


16. Guo D, Wu C, Li J, Guo A, Li Q, Jiang H, et al. Synergistic effect of functionalized nickel nanoparticles and quercetin on inhibition of the SMMC-7721 cells proliferation. Nanoscale research letters. 2009;4(12):1395-402.


17. Ackland ML, Van De Waarsenburg S, Jones R. Synergistic antiproliferative action of the flavonols quercetin and kaempferol in cultured human cancer cell lines. In vivo. 2005;19(1):69-76.


18. Cárdenas-Triviño G, Monsalve-Rozas S, Vergara-González L. Microencapsulation of Erlotinib and Nanomagnetite Supported in Chitosan as Potential Oncologic Carrier. Polymers. 2021;13(8):1244.


19. Suryavanshi VS, Maharana T, Jagtap PK. Microencapsulation of Cassia fistula Flower Extract with Chitosan and its Antibacterial Studies. Current Drug Delivery. 2021.


20. Santos MA, Machado MT. Coated alginate–chitosan particles to improve the stability of probiotic yeast. International Journal of Food Science & Technology. 2021;56(5):2122-31.


21. Marslin G, Revina AM, Khandelwal VKM, Balakumar K, Prakash J, Franklin G, et al. Delivery as nanoparticles reduces imatinib mesylate-induced cardiotoxicity and improves anticancer activity. International journal of nanomedicine. 2015;10:3163.


22. محمد ش, پدرام ان, محمود ا, امیر ش, زاوش زز. بررسی سمیت سلولی نانو ذرات داروی Docetaxel با استفاده از کشت سلول های سرطانی HepG2.


23. Khakrizi E, BikhofTorbati M, Shaabanzadeh M. The Study of Anticancer Effect of Magnetic Chitosan-Hydroxyurea Nanodrug on HeLa Cell line: A Laboratory Study. Journal of Rafsanjan University of Medical Sciences. 2018;17(8):715-30.


24. Feng C, Wang Z, Jiang C, Kong M, Zhou X, Li Y, et al. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation. International journal of pharmaceutics. 2013;457(1):158-67.


25. Hou Z, Zhan C, Jiang Q, Hu Q, Li L, Chang D, et al. Both FA-and mPEG-conjugated chitosan nanoparticles for targeted cellular uptake and enhanced tumor tissue distribution. Nanoscale research letters. 2011;6(1):1-11.


26. Cao X, Chen C, Yu H, Wang P. Horseradish peroxidase-encapsulated chitosan nanoparticles for enzyme-prodrug cancer therapy. Biotechnology letters. 2015;37(1):81-8.